This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010
Title: Mavurapu Satyanarayana: Innovator in Antihyperglycemic Agents
Introduction
Mavurapu Satyanarayana is a notable inventor based in Lucknow, India. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that exhibit antihyperglycemic and antidyslipidemic properties. His work is crucial in addressing metabolic disorders such as diabetes.
Latest Patents
Satyanarayana holds a patent for "Oxy substituted chalcones as antihyperglycemic and antidyslipidemic agents." This invention provides appropriately substituted chalcones, represented by a specific structural formula. The compounds are designed with various substituents, including H, OH, O-alkyl, and O-phenyl. The patent highlights the potential of these compounds to exhibit significant antidiabetic effects in various animal models, indicating their potential for further exploitation in therapeutic applications.
Career Highlights
Throughout his career, Mavurapu Satyanarayana has focused on innovative research that bridges the gap between chemistry and medicine. His dedication to developing effective treatments for diabetes showcases his commitment to improving public health. With one patent to his name, he continues to contribute to the scientific community.
Collaborations
Satyanarayana has collaborated with notable colleagues, including Ram Pratap and Chandeshwar Nath. These partnerships have fostered a collaborative environment that enhances the research and development of new medicinal compounds.
Conclusion
Mavurapu Satyanarayana is a distinguished inventor whose work in developing antihyperglycemic agents has the potential to make a significant impact on diabetes treatment. His innovative approach and dedication to research exemplify the spirit of invention in the field of medicinal chemistry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile